Tema Neuroscience And Men... (MNTL)
NASDAQ: MNTL
· Real-Time Price · USD
23.80
0.06 (0.25%)
At close: Aug 06, 2025, 11:27 AM
0.25% (1D)
| Bid | 21.13 |
| Market Cap | 10.33M |
| AUM | 10.28M |
| NAV | 23.37 |
| EPS (ttm) | 1.09 |
| PE Ratio (ttm) | 21.76 |
| Shares Out | 433.86K |
| Inception Date | Jan 22, 2024 |
| Ask | 22.64 |
| Volume | 133 |
| Open | 23.80 |
| Previous Close | 23.74 |
| Day's Range | 23.80 - 23.80 |
| 52-Week Range | 19.86 - 27.66 |
| Holdings | 4 |
| Expense Ratio | 0.75% |
About MNTL
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
Asset Class Equity
Ticker Symbol MNTL
Inception Date Jan 22, 2024
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 55.49% of assets
| Name | Symbol | Weight |
|---|---|---|
| Vertex Pharmaceutica... | VRTX | 10.33% |
| Regeneron Pharmaceut... | REGN | 8.09% |
| Alnylam Pharmaceutic... | ALNY | 7.74% |
| Argenx Se | ARGX | 5.83% |
| Neurocrine Bioscienc... | NBIX | 4.89% |
| Teva Pharmaceutical ... | TEVA | 4.32% |
| Eli Lilly And Compan... | LLY | 4.05% |
| Crinetics Pharmaceut... | CRNX | 3.54% |
| Ionis Pharmaceutical... | IONS | 3.48% |
| Stryker Corporation | SYK | 3.22% |
Dividends Dividend Yield 1%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 11, 2024 | $0.2570 | Dec 12, 2024 |
